Population-based risk assessment for other cancers in relatives of Hereditary Prostate Cancer (HPC) cases

Prostate

Volumn 64, Issue 4, 2005, Pages 347-355

  Albright, Lisa A Cannon ^a,c   Schwab, Angela ^b   Camp, Nicola J ^a   Farnham, James S ^a   Thomas, Alun ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Genetic Epidemiology Group   (United States)

Author keywords

Hereditary prostate cancer; Prostate cancer syndromes; Relative risk

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER RISK; COLON CANCER; FEMALE; GALLBLADDER CANCER; HEREDITARY PROSTATE CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PEDIGREE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RISK ASSESSMENT;

ADULT; AGE OF ONSET; FAMILY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; PROSTATIC NEOPLASMS; REGISTRIES; RISK ASSESSMENT; UTAH;

EID: 23944498935     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20248     Document Type: Article

References (23)

1. Woolf CM: An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960;13:739-744.
2. Cannon LA, Bishop DT, Skolnick M, Hunt S, Lyon L, Smart CR: Genetic epidemiology of prostate cancer in Utah Mormon Genealogy. Cancer Surv 1982;1:47-69.
3. Goldgar DE, Easton DF, Cannon Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first degree relatives of cancer probands. JNCI 1994;86:1600-1605.
4. Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003;91(9):789-794.
5. Eldon BJ, Jonsson E, Tomasson J, Tryggvadottir L, Tulinius H. Familial risk of prostate cancer in Iceland. BJU Int 2003;92(9): 915-919.
6. Matikainen MP, Pukkala E, Schleutker J, Tammela TLJ, Koivisto P, Sankila R, Kallioniemi OP. Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: A population-based, cancer registry study in Finland. Cancer Causes Control 2001;12:223-230.
7. Skolnick M, Bishop DT, Carmelli D, Gardner E, Hadley R, Hasstedt S, Hill JR, Hunt S, Lyon JL, Smart CR, Williams RR. A population-based assessment of familial cancer risk in Utah Mormon genealogies. In: Arrighi FE, Rao PN, Stubblefield E, editors. Genes, chromosomes, and neoplasia, New York: Raven Press; 1981. pp 477-500.
8. Bishop DT, Skolnick MH. Genetic epidemiology of cancer in Utah genealogies: A prelude to the molecular genetics of common cancers. In: Mak TW, Tannock I, editors. Cellular and Molecular Biology of Neoplasia. J Cell Phys Supp 1984;3: 63-77.
9. Cannon Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter W, Skolnick MH. Familiaity of cancer in Utah. Cancer Res 1994;54:2378-2385.
10. Thomas A, Cannon-Albright L, Bansal A, Skolnick MH. Familial associations between cancer sites. Comput Biomed Res 1999; 32(6)517-529.
11. Skolnick M: The Utah genealogical data base: A resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick M, editors. Banbury Report no 4: Cancer incidence in defined populations. New York: Cold Spring Harbor Laboratory; 1980; pp 285-297.
12. McClellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-837.
13. Jorde LB. Inbreeding in the Utah Mormons: An evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 1989;53:339-355.
14. Cancer in Utah 1966-1994. Utah Cancer Registry: Utah; 1996.
15. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17:337-347.
16. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T. Family history and prostate cancer risk in Black, White, and Asian men in the United States and Canada. Can Am J Epidemiol 1995;141:732-740.
17. Bratt O, Kristoffersson U, Lundgren R, Olsson H. The risk of malignant tumours in first degree relatives of men with early onset prostate cancer: A population based cohort study. Eur J Cancer 1997;33(13):2237-2240.
18. Valeri A, Fournier G, Morin V, Morin JF, Drelon E, Mangin P, Teillac P, Barthon P, Cussenot O. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. In J Cancer 2000;86:883-887.
19. Gronberg H, Bergh A, Damber JE, Emanuelsson M. Cancer risk in families with hereditary prostate carcinoma. Cancer 2000;89(6):1315-1321.
20. Isaacs SD, Kiemeney LALM, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. JNCI 1995;87:991-996.
21. Baffoe-Bonnie A, Kiemeney LALM, Beaty TH, Bailey-Wilson JE, Schnell AH, Sigvaldason H, Olafsdottir G, Tryggvadottir L, Tulinius H. Segregation analysis of 389 Icelandic pedigrees with breast and prostate cancer. Gen Epi 2002;23:349-363.
22. Arason A, Barkardottir RB, Egilsson V. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families and possible relationship to prostatic cancer. Am J Hum Genet 1993;52:711-717.
23. Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, Murkin A, Dowe A, Kelly J, Williams S, Oram R, Stevens M, Teare DM, Ponder BAJ, Gayther SA, The Cancer Research UK/British Prostate Group UK Familial Prostate Cancer Study Collaborators, British Association of Urological Surgeons Section of Oncology, Easton DF, Eeles RA. Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 2003;72:1-12.